AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 1 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $266,000 | +10.8% | 28,393 | -9.8% | 0.00% | 0.0% |
Q2 2020 | $240,000 | +23.7% | 31,463 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $194,000 | -37.6% | 31,463 | +22.9% | 0.00% | -25.0% |
Q4 2019 | $311,000 | +3.7% | 25,608 | -1.7% | 0.00% | 0.0% |
Q3 2019 | $300,000 | +163.2% | 26,054 | +126.9% | 0.00% | +100.0% |
Q2 2019 | $114,000 | -24.0% | 11,481 | -1.9% | 0.00% | -33.3% |
Q1 2019 | $150,000 | -14.3% | 11,701 | +1.0% | 0.00% | 0.0% |
Q4 2018 | $175,000 | -22.6% | 11,581 | +2.3% | 0.00% | -25.0% |
Q3 2018 | $226,000 | +3.7% | 11,321 | +0.9% | 0.00% | 0.0% |
Q2 2018 | $218,000 | -1.8% | 11,221 | +1.4% | 0.00% | -20.0% |
Q1 2018 | $222,000 | +138.7% | 11,061 | +57.1% | 0.01% | +150.0% |
Q4 2017 | $93,000 | -27.3% | 7,041 | +1.4% | 0.00% | -66.7% |
Q3 2017 | $128,000 | +1.6% | 6,941 | +1.0% | 0.01% | -33.3% |
Q2 2017 | $126,000 | +48.2% | 6,871 | +81.3% | 0.01% | +50.0% |
Q1 2017 | $85,000 | -33.6% | 3,790 | +2.4% | 0.01% | -50.0% |
Q4 2016 | $128,000 | – | 3,700 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ARMISTICE CAPITAL, LLC | 4,060,000 | $46,893,000 | 3.11% |
Camber Capital Management LP | 4,390,000 | $50,705,000 | 2.67% |
Palo Alto Investors LP | 3,078,874 | $35,561,000 | 2.37% |
Permanens Capital L.P. | 407,811 | $4,710,000 | 1.32% |
Fondren Management LP | 35,000 | $404,000 | 0.34% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 33,524 | $387,000 | 0.29% |
BOOTHBAY FUND MANAGEMENT, LLC | 240,000 | $2,772,000 | 0.25% |
Broadfin Capital, LLC | 100,000 | $1,155,000 | 0.21% |
FOX RUN MANAGEMENT, L.L.C. | 13,687 | $158,000 | 0.14% |
Spark Investment Management LLC | 92,200 | $1,064,000 | 0.14% |